Botti & Ferrari competitive analysis

Explore patent oppositions filed by Botti & Ferrari against competitors, revealing strategic technology disputes and market positioning.

Last updated on: May 21, 2026
Patent NumberTitleApplicantOpposition Date
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 9, 2026
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECHDec 29, 2025
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF HOFFMANN LA ROCHEDec 19, 2025
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICALJun 11, 2025
Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMASep 17, 2024
Combination Therapy For CopdCHIESI FARMACEUTICIJul 3, 2024
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 26, 2024
Methods Of Using Pyruvate Kinase ActivatorsAGIOS PHARMACEUTICALSJun 11, 2024

Latest PTAB cases involving Botti & Ferrari

Discover the latest PTAB cases involving Botti & Ferrari, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Botti & Ferrari with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: May 21, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOTTI & FERRARI18 - - -
ALFASIGMA510 - -
ALFA WASSERMANN - 6 - -
ARCHIMEDE SOLAR ENERGY - 1 - -